India’s cumulative vaccination coverage over 176 Crore landmark milestone

New Delhi: India’s COVID-19 vaccination coverage has crossed 176 Crore landmark milestone (1,76,15,75,119) today. More than 30 lakh (30,62,731) Vaccine Doses have been administered till 7 pm today. More than 1.93 Crore (1,93,49,127) Precaution Doses for the identified categories of beneficiaries (HCWs, FLWs and Over 60 years) for COVID vaccination have been administered so far. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10400972
	2^nd Dose	9957377
	Precaution Dose	4091515
FLWs	1^st Dose	18408432
	2^nd Dose	17425649
	Precaution Dose	6005426
Age Group 15-18 years	1^st Dose	54074256
	2^nd Dose	23793741
Age Group 18-44 years	1^st Dose	550845053
Age Group 18-44 years	2^nd Dose	438547279
Age Group 45-59 years	1^st Dose	202116327
Age Group 45-59 years	2^nd Dose	178920041
Over 60 years	1^st Dose	126278722
	2^nd Dose	111458143
	Precaution Dose	9252186
Cumulative 1^st dose administered		962123762
Cumulative 2^nd dose administered		780102230
Precaution Dose		19349127
Total		1761575119

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 22^nd February, 2022 (403^rd Day)
HCWs	1^st Dose	97
	2^nd Dose	2132
	Precaution Dose	19998
FLWs	1^st Dose	229
	2^nd Dose	3207
	Precaution Dose	56051
Age Group 15-18 years	1^st Dose	171743
	2^nd Dose	922958
Age Group 18-44 years	1^st Dose	200406
Age Group 18-44 years	2^nd Dose	1139295
Age Group 45-59 years	1^st Dose	30375
Age Group 45-59 years	2^nd Dose	236237
Over 60 years	1^st Dose	26850
	2^nd Dose	147054
	Precaution Dose	106099
Cumulative 1^st dose administered		429700
Cumulative 2^nd dose administered		2450883
Precaution Dose		182148
Total		3062731

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.